Nathan Kerr

This user account status is Approved
Kerr
Nathan
Australia
Principal Investigator, Glaucoma

Centre for Eye Research Australia

Glaucoma Section Editor, Clinical and Experimental Ophthalmology.
Editorial Board Member, Translational Vision Science and Technology.

Clinical trials, registries, glaucoma surgery, minimally invasive glaucoma surgery.


Sessions


Wednesday 1.00pm-2.00pmPlenary 2

SANTEN - Innovation in surgical management of glaucoma

Chair(s): Nathan Kerr (Australia);

Friday 3.45 pm-4.45 pmRoom 212 & 213

Glaucoma and lens extraction: where are we?

Chair(s): Vital Costa (Brazil); Jian Ge (China);

Friday 5.00 pm-6.00 pmMelbourne Room

Rapid Fire Session 2

Chair(s): Ivan Goldberg (Australia); Parul Ichhpujani (India); Eddie Kgao Legodi (South Africa);

  • 5.00-5.05
    XEN Gel Stent Surgery in Patients with Open Angle Glaucoma: Two-Year Results
    Alice Di Domenico (Italy)
  • 5.05-5.10
    Outcomes of combined trabeculotomy with trabeculectomy in children with Aniridia and secondary glaucoma.
    Nkechinyere Judith Uche (India)
  • 5.10-5.15
    Trabecular Micro-Bypass with Cataract Surgery for Patients with Glaucoma: A Systematic Review and Meta-Analysis
    Nathan Kerr (Australia)
  • 5.15-5.20
    Comparison of bleb morphology by conjunctival incision after trabeculectomy
    Hailong Huang (Japan)
  • 5.20-5.25
    Multicenter, randomized study of a SchlemmÂ’s canal microstent for reduction of IOP in primary open angle glaucoma (The HORIZON Trial)
    Cathleen McCabe (United States)
  • 5.25-5.30
    Real World MIGS: Australian & New Zealand experience of > 1000 Hydrus Microstent implants with 1 to 3 year follow up.
    Ashish Agar (Australia)
  • 5.30-5.35
    Post-operative outcomes of revision surgery for failed XEN Implants at a UK tertiary eye centre
    Emma Linton (United Kingdom)
  • 5.35-5.40
    Ab interno gel implant for the treatment of refractory glaucoma: results from the International Glaucoma Surgery Registry (IGSR)
    Nathan Kerr (Australia)
  • 5.40-5.45
    Lens Extraction with or without Goniosynechialysis in Primary Angle Closure Disease for angle parameters assessment.
    Jyoti Shakrawal (India)
  • 5.45-5.50
    Risk factors for corneal endothelial cell loss after trabeculectomy with mitomycin C
    Tomomi Higashide (Japan)
  • 5.50-5.55
    Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome.
    Van Tao Tran (Switzerland)

Saturday 8.30 am-10.00 amRoom 111 & 112

First experiences with XEN®

Chair(s): Gus Gazzard (United Kingdom); Tarek Shaarawy (Switzerland); TBA; Andrew White (Australia); Bill Morgan (Australia); Leon Au (United Kingdom); Nathan Kerr (Australia);

    Contact

    Please contact our Professional Congress Organizer MCI for all your WGC-2019 questions

    MCI Amsterdam
    Schipluidenlaan 4
    1062 HE Amsterdam
    The Netherlands
    www.mci-group.com
    wgc@mci-group.com